City of Jacksonville Awards Legal Contract to Amneal Pharmaceuticals LLC (September 2025)
- Approved
- Sep 15, 2025
The 30-second brief
The Public Health and Safety Committee approved Jacksonville’s participation in the State’s opioid settlement with Amneal Pharmaceuticals LLC by authorizing execution of participation forms. This joins the City to a broader statewide recovery effort against opioid manufacturers and distributors.
Amneal Pharmaceuticals LLC holds this legal contract with City of Jacksonville. Its other public contracts on record include work for Pharmaceutical and Therapeutics Committee | State of Connecticut and Coahoma County.
See every contract and contact at City of Jacksonville.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Legal
- Document date
- September 15, 2025
- Agency
- City of Jacksonville
- Source document
- city-of-jacksonville-meeting-minutes-september-15-2025_760.pdf (Minutes)
Amneal Pharmaceuticals LLC's other public contracts
More City of Jacksonville contracts
Questions about this contract
Who was awarded the legal contract by City of Jacksonville?
Amneal Pharmaceuticals LLC was awarded this legal contract by City of Jacksonville, as recorded on September 15, 2025.
What type of contract is this?
This is a Legal contract, documented as a minutes record.
Where was this contract approved?
This contract appears in city-of-jacksonville-meeting-minutes-september-15-2025_760.pdf (Minutes), dated September 15, 2025 from City of Jacksonville. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Amneal Pharmaceuticals LLC hold?
Amneal Pharmaceuticals LLC may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is City of Jacksonville currently buying?
Explore City of Jacksonville's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.